PulseAugur
LIVE 12:29:38
research · [1 source] · · 中文(ZH) 阳光诺和:STC009注射液临床试验申请获受理

China fines Tiger, Futu, Changqiao for illegal securities operations

China's securities regulator is proposing significant penalties for Tiger Brokers, Futu, and Changqiao. These platforms are accused of illegally operating securities brokerage, margin financing, and futures brokerage services within mainland China without proper authorization. The regulator intends to confiscate all illegal gains and impose severe fines, while also offering the companies the right to a hearing. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

RANK_REASON Regulatory action by a national securities commission against major financial platforms. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Sunshine Noah: STC009 Injection Clinical Trial Application Accepted

    36氪获悉,阳光诺和公告,近日,公司全资子公司成都诺和晟泰生物科技有限公司收到国家药品监督管理局核准签发的《受理通知书》,在研项目STC009注射液的临床试验申请获得受理。STC009注射液拟申报适应症为继发性甲状旁腺功能亢进症(SHPT)。